Tumor fraction in cell-free DNA as a biomarker in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor fraction in cell-free DNA as a biomarker in prostate cancer

Published:2018-11-02 Issue:21 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Choudhury Atish D.,Werner Lillian,Francini Edoardo^ORCID,Wei Xiao X.,Ha Gavin^ORCID,Freeman Samuel S.,Rhoades Justin^ORCID,Reed Sarah C.,Gydush Gregory,Rotem Denisse,Lo Christopher,Taplin Mary-Ellen,Harshman Lauren C.,Zhang Zhenwei,O’Connor Edward P.,Stover Daniel G.,Parsons Heather A.^ORCID,Getz Gad^ORCID,Meyerson Matthew,Love J. Christopher^ORCID,Hahn William C.^ORCID,Adalsteinsson Viktor A.

Funder

Wong Family Award in Translational Oncology

Dana-Farber Cancer Institute Medical Oncology grant

Gerstner Family Foundation

Janssen Pharmaceuticals, Inc

National Cancer Institute

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/122109/files/pdf

Reference33 articles.

1. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

2. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors

3. Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy;Hovelson;Oncotarget,2017

4. Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review

5. Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial;European Urology Oncology;2024-09

2. Genomic alterations and transcriptional phenotypes in circulating tumor DNA and matched metastatic tumor;2024-06-03

3. Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer;Cancer;2024-06-02

4. Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers;The Journal of Molecular Diagnostics;2024-05

5. Principles of digital sequencing using unique molecular identifiers;Molecular Aspects of Medicine;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3